Abstract
Ushbu maqolada bakteriyalarda antibiotik rezistentligining shakllanish biologik mexanizmlari, uning tarqalish yo'llari, klinik va epidemiologik ahamiyati hamda rezistentlikni nazorat qilishning zamonaviy usullari ko'rib chiqilgan.
References
[1]. WHO (2023). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. – Geneva: World Health Organization. – 132 p.
[2]. Drawz S.M., Bonomo R.A. Three decades of beta-lactamase inhibitors // Clinical Microbiology Reviews. – 2010. – Vol. 23, No. 1. – P. 160–201.
[3]. Lakhundi S., Zhang K. Methicillin-resistant Staphylococcus aureus: Molecular characterization, evolution, and epidemiology // Clinical Microbiology Reviews. – 2018. – Vol. 31, No. 4. – e00020-18.
[4]. Li X.Z., Plésiat P., Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria // Clinical Microbiology Reviews. – 2015. – Vol. 28, No. 2. – P. 337–418.
[5]. Partridge S.R. et al. Mobile genetic elements associated with antimicrobial resistance // Clinical Microbiology Reviews. – 2018. – Vol. 31, No. 4. – e00088-17.
[6]. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: A common cause of persistent infections // Science. – 1999. – Vol. 284, No. 5418. – P. 1318–1322.
[7]. Bengtsson-Palme J. et al. The role of the environment in the emergence of antibiotic resistance // Microbial Biotechnology. – 2018. – Vol. 11, No. 6. – P. 1–11.